Form D · Pharmaceuticals
PhytoCeutica, Inc.
New Haven, CT · CIK 0001506496
Offering snapshot reported Dec 1, 2010 · SEC filing
- Reported sold
- $2M Offering amount: $4.5M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 16, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 1, 2010 | Initial | $2,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-151237
The Issuer does not intend to sell the remaining $2,500,000 of securities
All securities are preferred stock convertible into common stock of Issuer
Source: Form D, filed Dec 1, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Shwu Huey Liu | Executive |
| Jonathan Soderstrom | Director |
| Robert Tilton | Executive |
| Tsang Bin Tzeng | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
5 Science Park, Box 13
New Haven, CT, 06511
New Haven, CT, 06511